Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Insmed (INSM)

Add to Watchlists
Create an Alert
14.12 -0.39  -2.69% NASDAQ Apr 24, 3:03PM BATS Real time Currency in USD
View Full Chart
INSM Price Chart
View All Events

INSM Events

Date Type Description
Mar 06 Earnings Insmed, Inc. Q4 2013 Earnings Results. Estimate: -0.40.
Nov 05 Misc Insmed to Host Third Quarter 2013 Financial Results Conference Call
Nov 05 Earnings Insmed to Host Third Quarter 2013 Financial Results. Estimate: -0.34.
Aug 06 Misc Insmed to Host Second Quarter 2013 Financial Results Conference Call on Tuesday, August 6, 2013
Aug 06 Earnings Insmed Announces Second Quarter 2013 Financial Results. Estimate: -0.42.
May 23 Misc AGM Event for Insmed Inc
May 07 Misc Insmed to Host First Quarter 2013 Financial Results Conference Call on Tuesday, May 7, 2013
May 07 Earnings Nsmed to Host First Quarter 2013 Financial Results Conference Call on Tuesday, May 7, 2013. Estimate: -0.38.
View All Performance Charts

INSM Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Insmed is up 87.27% over the last year vs S&P 500 Total Return up 21.55%, Alexion Pharmaceuticals up 70.49%, and Alkermes up 46.77%.

Get Quote for

PDF Report for INSM

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download INSM Pro Report PDF
Advertisement

Portfolio Strategies Featuring INSM

Did Insmed make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

INSM Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: New Jersey
  • Incorporation Country: United States
  • Incorporation State/Province: Virginia
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Insmed, Inc. is a biopharmaceutical company engaged in developing and commercializing inhaled therapies for patients battling serious lung diseases that are often life threatening. Its lead product candidate is ARIKAYCE.

Recent Quotes

Symbol Price Chg Chg % Market Cap
INSM 14.12 -0.39 -2.69% 554.40M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.